Related references
Note: Only part of the references are listed.mtDNA copy number associated with age of onset in familial amyloid polyneuropathy
Diana Santos et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2018)
A Trans-acting Factor May Modify Age at Onset in Familial Amyloid Polyneuropathy ATTRV30M in Portugal
Miguel Alves-Ferreira et al.
MOLECULAR NEUROBIOLOGY (2018)
Long-term treatment of transthyretin familial amyloid polyneuropathy with tafamidis: a clinical and neurophysiological study
Violaine Plante-Bordeneuve et al.
JOURNAL OF NEUROLOGY (2017)
Clinical measures in transthyretin familial amyloid polyneuropathy
Teresa Coelho et al.
MUSCLE & NERVE (2017)
Familial amyloid polyneuropathy in Portugal: New genes modulating age-at-onset
Diana Santos et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2017)
Non-coding variants contribute to the clinical heterogeneity of TTR amyloidosis
Andrea Iorio et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2017)
Diagnostic challenges in hereditary transthyretin amyloidosis with polyneuropathy: avoiding misdiagnosis of a treatable hereditary neuropathy
Andrea Cortese et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2017)
Clinical features of familial amyloid polyneuropathy carrying transthyretin mutations in four Chinese kindreds
Gonglu Liu et al.
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM (2017)
ASSESSING MNIS+7IONIS AND INTERNATIONAL NEUROLOGISTS' PROFICIENCY IN A FAMILIAL AMYLOIDOTIC POLYNEUROPATHY TRIAL
Peter J. Dyck et al.
MUSCLE & NERVE (2017)
Early skin denervation in hereditary and iatrogenic transthyretin amyloid neuropathy
Teruaki Masuda et al.
NEUROLOGY (2017)
Sural nerve injury in familial amyloid polyneuropathy MR neurography vs clinicopathologic tools
Jennifer Kollmer et al.
NEUROLOGY (2017)
Long-term safety and efficacy of tafamidis for the treatment of hereditary transthyretin amyloid polyneuropathy: results up to 6 years
Fabio A. Barroso et al.
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS (2017)
Cognitive impairment in liver transplanted patients with transthyretin-related hereditary amyloid polyneuropathy
Vanda Freitas Castro et al.
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS (2017)
Cutaneous Nerve Biomarkers in Transthyretin Familial Amyloid Polyneuropathy
Gigi J. Ebenezer et al.
ANNALS OF NEUROLOGY (2017)
Design and Rationale of the Phase 3 ATTR-ACT Clinical Trial (Tafamidis in Transthyretin Cardiomyopathy Clinical Trial)
Mathew S. Maurer et al.
CIRCULATION-HEART FAILURE (2017)
Refine penetrance estimates in the main pathogenic variants of transthyretin hereditary (familial) amyloid polyneuropathy (TTR-FAP) using a new non-parametric approach (NPSE)
Farida Gorram et al.
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS (2017)
Novel Screening for Transthyretin Amyloidosis by Using Fat Ultrasonography
Yohei Misumi et al.
ANNALS OF NEUROLOGY (2017)
Prevalence and clinical phenotype of hereditary transthyretin amyloid cardiomyopathy in patients with increased left ventricular wall thickness
Thibaud Damy et al.
EUROPEAN HEART JOURNAL (2016)
Variants in RBP4 and AR genes modulate age at onset in familial amyloid polyneuropathy (FAP ATTRV30M)
Diana Santos et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2016)
A study of the neuropathy associated with transthyretin amyloidosis (ATTR) in the UK
A. S. Carr et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2016)
Early intervention with tafamidis provides long-term (5.5-year) delay of neurologic progression in transthyretin hereditary amyloid polyneuropathy
Marcia Waddington Cruz et al.
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS (2016)
Suppressing transthyretin production in mice, monkeys and humans using 2nd-Generation antisense oligonucleotides
Elizabeth J. Ackermann et al.
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS (2016)
Novel conformation-specific monoclonal antibodies against amyloidogenic forms of transthyretin
Jeffrey N. Higaki et al.
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS (2016)
Transthyretin amyloid neuropathy has earlier neural involvement but better prognosis than primary amyloid counterpart: an answer to the paradox?
Adam J. Loavenbruck et al.
ANNALS OF NEUROLOGY (2016)
Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis
Julian D. Gillmore et al.
CIRCULATION (2016)
The diagnostic accuracy of Sudoscan in transthyretin familial amyloid polyneuropathy
Jose Castro et al.
CLINICAL NEUROPHYSIOLOGY (2016)
Current and Future Treatment Approaches in Transthyretin Familial Amyloid Polyneuropathy
Philippe Kerschen et al.
CURRENT TREATMENT OPTIONS IN NEUROLOGY (2016)
Monitoring effectiveness and safety of Tafamidis in transthyretin amyloidosis in Italy: a longitudinal multicenter study in a non-endemic area
A. Cortese et al.
JOURNAL OF NEUROLOGY (2016)
Red-flag symptom clusters in transthyretin familial amyloid polyneuropathy
Isabel Conceicao et al.
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM (2016)
Management of asymptomatic gene carriers of transthyretin familial amyloid polyneuropathy
Hartmut H-J. Schmidt et al.
MUSCLE & NERVE (2016)
Schwann cell and endothelial cell damage in transthyretin familial amyloid polyneuropathy
Haruki Koike et al.
NEUROLOGY (2016)
Cerebral amyloid angiopathy in posttransplant patients with hereditary ATTR amyloidosis
Yoshiki Sekijima et al.
NEUROLOGY (2016)
Peripheral Blood Cell Gene Expression Diagnostic for Identifying Symptomatic Transthyretin Amyloidosis Patients: Male and Female Specific Signatures
Sunil M. Kurian et al.
THERANOSTICS (2016)
The prevalence and distribution of the amyloidogenic transthyretin (TTR) V122I allele in Africa
Daniel R. Jacobson et al.
MOLECULAR GENETICS & GENOMIC MEDICINE (2016)
Safety and efficacy of long-term diflunisal administration in hereditary transthyretin (ATTR) amyloidosis
Yoshiki Sekijima et al.
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS (2015)
Genotype-Phenotype Correlation and Course of Transthyretin Familial Amyloid Polyneuropathies in France
Louise-Laure Mariani et al.
ANNALS OF NEUROLOGY (2015)
Diagnosis, Prognosis, and Therapy of Transthyretin Amyloidosis
Morie A. Gertz et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2015)
Liver Transplantation in Transthyretin Amyloidosis: Issues and Challenges
Andreia Carvalho et al.
LIVER TRANSPLANTATION (2015)
Therapeutic Clearance of Amyloid by Antibodies to Serum Amyloid P Component
Duncan B. Richards et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
The Amyloidogenic V122I Transthyretin Variant in Elderly Black Americans
C. Cristina Quarta et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Liver Transplantation for Hereditary Transthyretin Amyloidosis: After 20 Years Still the Best Therapeutic Alternative?
Bo-Goran Ericzon et al.
TRANSPLANTATION (2015)
In vivo detection of nerve injury in familial amyloid polyneuropathy by magnetic resonance neurography
Jennifer Kollmer et al.
BRAIN (2015)
CNS involvement in V30M transthyretin amyloidosis: clinical, neuropathological and biochemical findings
Luis F. Maia et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2015)
Antibodies and protein misfolding: From structural research tools to therapeutic strategies
Erwin De Genst et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2014)
Update in the diagnosis and management of transthyretin familial amyloid polyneuropathy
Violaine Plante-Bordeneuve
JOURNAL OF NEUROLOGY (2014)
Repurposing Diflunisal for Familial Amyloid Polyneuropathy A Randomized Clinical Trial
John L. Berk et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Long-term effects of tafamidis for the treatment of transthyretin familial amyloid polyneuropathy
Teresa Coelho et al.
JOURNAL OF NEUROLOGY (2013)
Safety and Efficacy of RNAi Therapy for Transthyretin Amyloidosis
Teresa Coelho et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
AG10 inhibits amyloidogenesis and cellular toxicity of the familial amyloid cardiomyopathy-associated V122I transthyretin
Sravan C. Penchala et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Tafamidis for transthyretin familial amyloid polyneuropathy A randomized, controlled trial
Teresa Coelho et al.
NEUROLOGY (2012)
Tafamidis, a potent and selective transthyretin kinetic stabilizer that inhibits the amyloid cascade
Christine E. Bulawa et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Familial amyloid polyneuropathy
Violaine Plante-Bordeneuve et al.
LANCET NEUROLOGY (2011)
Antibodies to human serum amyloid P component eliminate visceral amyloid deposits
Karl Bodin et al.
NATURE (2010)
Lipid-like materials for low-dose, in vivo gene silencing
Kevin T. Love et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Orally administered diflunisal stabilizes transthyretin against dissociation required for amyloidogenesis
Yoshiki Sekijima et al.
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS (2006)
Targeted suppression of an amyloidogenic transthyretin with antisense oligonucleotides
MD Benson et al.
MUSCLE & NERVE (2006)
Prevention of transthyretin amyloid disease by changing protein misfolding energetics
P Hammarström et al.
SCIENCE (2003)
Share Paper
